Sunshine Biopharma's total assets for Q2 2025 were $31.97M, an increase of 9.52% from the previous quarter. SBFM total liabilities were $6.28M for the fiscal quarter, a -3.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.